DISCOVERY OF ADIPONECTIN AND ITS FUTURE PROSPECT
Journal: Journal of Dibetes and Obesity (Vol.1, No. 1)Publication Date: 2014-07-29
Abstract
Adiponectin is an adipocyte-specific protein abundantly present in the plasma. Since its discovery, numerous experimental and clinical studies have demonstrated that adiponectin has anti-atherogenic, antidiabetic and anti-inflammatory properties. Hypoadiponectinemia plays a key role in the pathogenesis of metabolic syndrome. In this manuscript, we review the discovery and establishment of adiponectin and discuss future prospects of this molecule.
Other Latest Articles
- FRUCTOSE INTAKE AND CIRCULATING TRIGLYCERIDES: AN EXAMINATION OF THE ROLE OF APOC 3
- FACTORS ASSOCIATED WITH METABOLIC SYNDROME IN PATIENTS WITH MENTAL DISORDERS IN MEXICO
- FASTING C-PEPTIDE INDEX MAY BE THE STRONGEST PREDICTOR FOR DETECTING EFFECTIVENESS OF GLYCEMIC CONTROL BY GLP-1 ANALOGUE, LIRAGLUTIDE THERAPY FOR JAPANESE TYPE 2 DIABETIC PATIENTS
- OBESITY-RELATED HORMONES AND METABOLIC RISK FACTORS: A RANDOMIZED TRIAL OF DIET PLUS EITHER STRENGTH OR AEROBIC TRAINING VERSUS DIET ALONE IN OVERWEIGHT PARTICIPANTS
- PATIENT EDUCATION MAY IMPROVE PERIOPERATIVE SAFETY
Last modified: 2017-01-10 16:00:33